A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery

Inclusion Criteria: * All women age ≥ 18 years (age of legal consent) * Singleton pregnancy \>= 34 weeks Exclusion Criteria: * Women planning for Caesarean section * Women with known risk factors for PPH, including grand multiparity (\>=4), multiple pregnancy, fibroid with size \>4cm, history of PPH, placenta previa, large-for-gestational age fetus (defined as EFW \>90th centile), polyhydramnios, and previous Caesarean section. * Women with bleeding tendency or thrombocytopenia \< 100 x 109/L * Women on anticoagulant or aspirin * Women in whom use of misoprostol / syntocinon / syntometrine is contraindicated * Women with known hypersensitivity to misoprostol / syntocinon / syntometrine